Provided herein is A compound of Formula I:

##STR00001##

or a pharmaceutically acceptable salt thereof, wherein the various substituents are described herein.

Provided herein is A compound of Formula I:

##STR00001##

or a pharmaceutically acceptable salt thereof, wherein the various substituents are described herein.

The present invention provides a process for producing the compound having the structure:

##STR00001##

comprising
(a) reacting a compound having the structure:

##STR00002##

with a compound having the structure:

##STR00003##

in the presence of a first organic solvent under conditions sufficient to produce the compound,
wherein the first organic solvent is a substituted benzene.

The present invention provides a process for producing the compound having the structure:

##STR00001##

comprising
(a) reacting a compound having the structure:

##STR00002##

with a compound having the structure:

##STR00003##

in the presence of a first organic solvent under conditions sufficient to produce the compound,
wherein the first organic solvent is a substituted benzene.

The invention provides a compound of Formula I: ##STR00001##
or a pharmaceutically acceptable salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of Formula I, processes for preparing compounds of Formula I, therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS symptoms in a mammal using compounds of Formula I.

The invention provides a compound of Formula I: ##STR00001##
or a pharmaceutically acceptable salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of Formula I, processes for preparing compounds of Formula I, therapeutic methods for treating the proliferation of the HIV virus, treating AIDS or delaying the onset of AIDS symptoms in a mammal using compounds of Formula I.

The invention relates to a process for preparing triaryl organoborates proceeding from organoboronic esters in the presence of an n-valent cation 1/n K.sup.n+, comprising the anhydrous workup of the reaction mixture and the use of the triaryl organoborates obtained as co-initiator in photopolymer formulations, holographic media and holograms.

The invention relates to a process for preparing triaryl organoborates proceeding from organoboronic esters in the presence of an n-valent cation 1/n K.sup.n+, comprising the anhydrous workup of the reaction mixture and the use of the triaryl organoborates obtained as co-initiator in photopolymer formulations, holographic media and holograms.

The invention relates to a process for preparing triaryl organoborates proceeding from organoboronic esters in the presence of an n-valent cation 1/n K.sup.n+, comprising the anhydrous workup of the reaction mixture and the use of the triaryl organoborates obtained as co-initiator in photopolymer formulations, holographic media and holograms.

The invention relates to a process for preparing triaryl organoborates proceeding from organoboronic esters in the presence of an n-valent cation 1/n K.sup.n+, comprising the anhydrous workup of the reaction mixture and the use of the triaryl organoborates obtained as co-initiator in photopolymer formulations, holographic media and holograms.